RECOMBINATE 1000 IU
国家: 以色列
语言: 英文
来源: Ministry of Health
该产品的某些文档当前不可用，您可以向我们的客户服务发送请求，我们将在获得它们后尽快通知您。
发送请求。
发送请求。
有效成分:
COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL
可用日期:
TEVA MEDICAL MARKETING LTD.
ATC代码:
B02BD02
药物剂型:
POWDER FOR SOLUTION FOR INJECTION
给药途径:
I.V
厂商:
BAXTER S.A., BELGIUM
治疗组:
COAGULATION FACTOR VIII
疗效迹象:
The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.
授权日期:
2010-07-01
